Parallax Health Sciences, Inc. PRLX OTC

Other OTC • Healthcare • Medical - Healthcare Information Services • US • USD

SharesGrow Score

29/100

0/5 Pass

SharesGrow Intrinsic Value

N/A

Negative cash flow

SharesGrow 7-Criteria Score All 7 criteria scored · valuation-related highlighted on this page

Parallax Health Sciences, Inc. (PRLX) .

本页证实的标准:

VALUE (0/100, 未通过) — 综合估值评分低于60/100的通过门槛。

SharesGrow 综合评分： 27/100 其中 0/7 项标准通过。

SharesGrow 7-Criteria Score

29/100

SG Score

View full scorecard →

—

价值

N/A

No coverage

—

未來

N/A

No coverage

✗

过去

25/100

→ Income

✗

健康

0/100

Debt-to-Equity & liquidity

→ Health

护城河

50/100

→ Income

成长

58/100

→ Income

✗

收入

10/100

→ Income

估值概览 — PRLX

估值倍数

P/E (TTM)0.0

前瞻 P/EN/A

PEG 比率N/A

前瞻 PEGN/A

P/B 比率0.00

P/S 比率0.20

EV/EBITDA0.0

每股数据

EPS (TTM)$-0.05

每股账面价值$0.00

每股营收$0.00

每股自由现金流$0.00

收益率与内在价值

盈利收益率N/A

股息收益率0.00%

EPS：实际 vs 预期

每股收益 (EPS) 历史

Year	EPS（稀释）	营收	净利润	净利润率
2010	$-0.12	$20.4K	$-5.13M	-25150.4%
2011	$-0.02	$192.25K	$-1.97M	-1023.3%
2012	$-0.01	$0.00	$-554.67K	-
2013	$0.00	$0.00	$-504.49K	-
2014	$-0.01	$0.00	$-1.11M	-
2015	$-0.03	$11.58M	$-3.42M	-29.5%
2016	$-0.07	$23.14M	$-8.23M	-35.6%
2017	$-0.08	$3.2M	$-13.88M	-434.3%
2018	$0.08	$11.74K	$16.29M	138762.4%
2019	$-0.05	$128.6K	$-12.87M	-10004.9%